STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition

Lin Chen(Xiamen University), Zhixian Wu(Bureau of Geology and Mineral Exploration and Development of Guizhou Province)

BioMed Research International

July 15, 2019

10.1155/2019/8042489

Cited by 33

Related Papers

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

|Annals of the Rheumatic Diseases|2008|540